Hi Jkj. Thanks for this.
The progress at RVX continues and this announcement indicates a few things;
- RVX is bringing a very high level of scientific expertise to the design and oversight of the BETonMACE phase lll clinical trial design.
- The fact that they can attract this level of expertise and reputation reinforces to me the belief of people with intimate knowledge of the MOA of rvx-208 in it's ability to reduce MACE under various indications.
- This team supplements all of the scientific knowledge at RVX, Eastern, NGN and Hepalink.
I'm long and this announcement continues to reinforce my position.
Enjoy the rest of the summer!
Cheers
Toinv :)
